Levensohn Venture Partners

Levensohn Venture Partners is a venture capital firm established in 1996, with its headquarters in San Francisco, California. The firm specializes in early and mid-stage investments, primarily focusing on information technology sectors such as digital media, security, demand-side cleantech, internet, enterprise software, communications equipment, and semiconductors. Within digital media, it emphasizes infrastructure, applications, analytics, and content, while its security investments target cyber, physical, and homeland security markets. The firm is particularly interested in demand-side cleantech technologies that enhance energy efficiency and infrastructure modernization. Levensohn typically invests between $500,000 and $5 million in initial rounds, with the possibility of additional investments in subsequent rounds. It aims to lead or co-lead these rounds and often seeks a board seat in its portfolio companies. The firm also explores special investment opportunities outside the early-stage focus, maintaining a diverse portfolio of over 60 active companies.

Tracy Saxton

Managing Director

82 past transactions

Authentic Vision

Series B in 2020
Authentic Vision GmbH is a company specializing in anti-counterfeiting and authentication technologies aimed at safeguarding investments in product innovation, brand value, and reputation. Founded in 2012 and headquartered in Salzburg, Austria, with an additional office in Saratoga, California, the company offers a unique solution that includes a patented label technology combining QR code features with holographic security aspects. Its flagship product, the CheckifReal application, allows users to visually distinguish between authentic and counterfeit labels. Additionally, Authentic Vision provides services for customer communication, client label management, and business intelligence. The company holds multiple patents and collaborates closely with universities and leading security printing firms to remain at the forefront of advancements in brand protection and consumer engagement solutions.

Aether Bio

Seed Round in 2020
Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to get the chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.

NativeWaves

Series A in 2020
NativeWaves is focused on enhancing the event viewing experience for audiences worldwide through its innovative audio synchronization and streaming technology. The company collaborates with partners to curate engaging content from live events and develops tools that facilitate personalized viewing experiences. By offering efficient and versatile content delivery solutions, NativeWaves allows for seamless integration into existing workflows without requiring major changes. Its software enables the translation of movies, sports events, and videos into multiple languages while eliminating issues such as buffering and synchronization delays. Additionally, users benefit from real-time access to live statistics and insights on alternate screens, allowing them to enjoy their favorite entertainment in a manner tailored to their preferences.

Cognition Therapeutics

Series B in 2020
Cognition Therapeutics, Inc. is a clinical-stage neuroscience company based in Pittsburgh, Pennsylvania, focused on developing small-molecule therapeutics for neurodegenerative and neuro-ophthalmic disorders. Founded in 2007, the company aims to restore normal cellular damage responses by targeting toxic proteins that contribute to cognitive decline, particularly in conditions such as Alzheimer's disease and dry age-related macular degeneration. Its lead product candidate, CT1812, is an orally administered drug designed to penetrate the blood-brain barrier and selectively bind to the S2R complex. Through its expertise in biological research and proprietary medicinal chemistry, Cognition Therapeutics is dedicated to creating innovative drug candidates that address significant unmet medical needs in the treatment of degenerative diseases.

Kineta (Reverse Merger With Yumanity Therapeutics)

Series C in 2020
Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Founded in December 2014 by award-winning protein folding expert, Susan Lindquist, and renowned biotech industry leader, Tony Coles, Yumanity is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs. The initial focus of the company is neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). The company’s proprietary platforms have already identified one potential new target for treating Parkinson’s disease, and Yumanity is actively advancing its new chemical lead series for this condition, as well as identifying additional compounds for Alzheimer’s disease and ALS.

Echo

Series A in 2020
Echo is a provider of am automated microscope intended for biological research and pathologies. The company's product provides features like inverted images, cell counting, phase contrast, brightfield and fluorescence, enabling customers to have accurate images at a lower cost.

Quince Therapeutics

Post in 2019
Quince Therapeutics is a preclinical stage biopharmaceutical company dedicated to developing innovative precision therapeutics for debilitating and rare diseases. The company has created a unique bone-targeting drug platform that enables the precise delivery of small molecules, peptides, or large molecules directly to the site of bone fractures and diseases. This targeted approach aims to enhance healing rates while minimizing off-target safety concerns often associated with non-targeted therapies. Quince Therapeutics focuses on addressing impairments related to strength, functionality, debilitating pain, and other serious health challenges.

Neuro Therapia

Series A in 2019
NeuroTherpia develop new therapies for diseases with an underlying component of neuroinflammation. Initial research has led to the development of our lead compound NTRX-07. NTRX-07 (previously known as MDA7) has been shown to decrease activation of microglial cells in the brain. Decreasing activation of these cells leads to decreased inflammation and decreased injury to surrounding nerve cells. Decreasing this inflammation can treat and even prevent the development of neuropathic pain in settings of nerve injury or chemotherapy. Recent work has shown that blocking this inflammation is also important in reversing the effects seen in Alzheimer's disease. We are currently doing preclinical safety studies and plan on studying NTRX-07 in humans in 2016.

Alzeca Biosciences

Series A in 2019
Alzeca Biosciences, Inc. is focused on developing advanced MRI-based imaging agents aimed at the early diagnosis of Alzheimer’s disease and other neurodegenerative disorders. Founded in 2011 and headquartered in Houston, Texas, the company is working on its primary product, the ADx nanoparticle, which serves as a magnetic resonance imaging contrast agent targeting amyloid plaques associated with Alzheimer's. This innovative approach allows for the detection of abnormal proteins that accumulate in the brain long before cognitive symptoms manifest, potentially facilitating earlier intervention. With Alzheimer's affecting millions of individuals worldwide and associated healthcare costs projected to soar, Alzeca's efforts are aligned with the urgent need for more effective diagnostic methods in the fight against neurodegenerative diseases.

Apres Therapeutics

Seed Round in 2019
Apres Therapeutics is a biotechnology company. The company is based in Wilmington, Delaware.

Aether Bio

Seed Round in 2019
Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to get the chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.

Lightform

Series A in 2019
Lightform, Inc. is a computer vision and hardware company based in San Francisco, California, founded in 2014. The company specializes in developing technology for projected augmented reality, offering sound-reactive projectors, projector kits, and creator products that transform spaces through projection mapping. Lightform's innovative hardware tools and desktop application enable users to create animated content for various scenes, control projectors wirelessly from laptops or phones, and seamlessly integrate real objects with projected light. The company also provides 3D scanning options that allow for the scanning of complex scenes, automatically fine-tuning alignment and enhancing the projection mapping workflow with AI-generated effects and filters.

Phase Four

Series A in 2019
Phase Four LLC, founded in 2015 and based in Pasadena, California, specializes in the manufacture of satellite propulsion systems, particularly for small satellites. The company is known for its innovative Radio Frequency Thruster (RFT), which distinguishes itself by omitting traditional components such as hollow cathodes and high voltage electronics. This design leads to substantial benefits, including a tenfold reduction in materials costs compared to legacy electric propulsion systems, a significant decrease in the size of power electronics, and versatility in propellant use. Phase Four's propulsion solutions are utilized in various space missions, including commercial, civil, and scientific endeavors, and are engineered to optimize performance while maintaining a competitive thrust-to-power ratio. The company also offers products like the CubeSats ambipolar thruster and the Maxwell plasma propulsion solution, contributing to the efficient maneuvering of satellites across diverse orbital trajectories.

NativeWaves

Series A in 2019
NativeWaves is focused on enhancing the event viewing experience for audiences worldwide through its innovative audio synchronization and streaming technology. The company collaborates with partners to curate engaging content from live events and develops tools that facilitate personalized viewing experiences. By offering efficient and versatile content delivery solutions, NativeWaves allows for seamless integration into existing workflows without requiring major changes. Its software enables the translation of movies, sports events, and videos into multiple languages while eliminating issues such as buffering and synchronization delays. Additionally, users benefit from real-time access to live statistics and insights on alternate screens, allowing them to enjoy their favorite entertainment in a manner tailored to their preferences.

Jawbone Health

Series A in 2019
Jawbone Health helps its users to catch lifestyle diseases early and guide them towards a healthier life. The company was founded in 2017 and based in San Francisco, California.

Kuprion

Series A in 2019
Kuprion’s™ revolutionary, copper based nanotechnology is a highly electrically conductive material enabling a new generation of printable electronics and integrated circuit chips. Connections between chip-to-chip or chip-to-board are up to 10 times the electrical and thermal conductivity of existing materials - perfect for smaller and more powerful products from phones to electric cars. Our nanoCopper technology is based on work that began at Lockheed Martin in 2008. They were researching ways to replace traditional solder with a high-performance, RoHS- compliant alternative for high-power, high-reliability applications. With widespread interest from the commercial sector, all rights and patents were transferred to Kuprion in 2019 to commercialize the family of pastes and inks. Since then, Kuprion has garnered Fortune 100 customers, 20 patents, and VC funding with offices and manufacturing in San Jose, CA

Virtual Power Systems

Series B in 2019
Virtual Power Systems, Inc. (VPS) is building a software-defined infrastructure for data center power delivery, employing its patent-pending power system virtualization technology to provide a more flexible, mobile, scalable, and lower-cost data center architecture.

Phylagen

Series A in 2019
Phylagen, Inc. is a data analytics company based in San Francisco that specializes in microbiome data analytics. Founded in 2014, the company employs DNA sequencing and machine learning to analyze complex genetic signatures within the environmental microbiome, transforming this extensive dataset into actionable insights for various industries. Phylagen also develops automated biosensors for indoor microbiome monitoring, which aim to enhance human health and safety by enabling early detection of pathogens, including COVID-19. Additionally, the company's solutions help manage allergy and asthma triggers, ensuring a healthier indoor environment for users.

Strateos

Series C in 2018
Strateos is a company that specializes in automating laboratory processes in chemistry, biology, and tissue analysis through its advanced robotic cloud laboratory platform. By integrating cutting-edge robotics with sophisticated software for imaging and analytics, Strateos provides pharmaceutical partners with the tools to accelerate drug discovery and development. The company emerged from a merger between Transcriptic, which pioneered on-demand robotic lab services, and 3Scan, known for its automation and machine learning capabilities in tissue analysis. Strateos aims to streamline the drug discovery process by offering a comprehensive suite of technologies that transform life science methods into data-driven solutions. This approach not only enhances productivity and efficiency but also redefines the traditional research model, making it more accessible and effective for scientists. Through its innovative platform, Strateos positions itself as a valuable partner in the life sciences sector, focusing on delivering significant time and cost savings in the drug development process.

Wickr

Series C in 2018
Wickr Inc. is a San Francisco-based company that specializes in mobile communication applications, offering military-grade encryption for text, images, audio, and video messages. Founded in 2011, Wickr provides users with secure communication channels through its platforms, including Wickr Me, which caters to individuals, small teams, and large enterprises. The application is designed to facilitate private messaging without leaving a trace, ensuring that only the intended recipient can decrypt the messages. Wickr's technology, which employs standard encryption algorithms, supports ephemeral messaging and media, making it suitable for a diverse clientele that includes journalists, government officials, medical professionals, and everyday users. With hundreds of thousands of downloads across over 113 countries, Wickr emphasizes user privacy and security, enabling anonymous communication while supporting the principles of free expression.

System1 Biosciences

Series A in 2018
System1 Biosciences, Inc. is a San Francisco-based neurotherapeutics company established in 2017, specializing in drug discovery for complex neurological and psychiatric disorders, including epilepsy, autism, and schizophrenia. The company employs phenotypic screening, integrating cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to uncover novel characterizations of diseases. This innovative approach allows System1 to identify "deep phenotypes," which are utilized to discover new therapeutic targets and drug treatments, addressing gaps in traditional discovery techniques that have struggled with these challenging conditions.

Atmosic

Series A in 2018
Atmosic Technologies is a fabless semiconductor company that specializes in ultra-low power wireless technologies aimed at enhancing the functionality of Internet of Things (IoT) devices. By leveraging ambient energy sources—such as light, radio frequency, thermal, and kinetic energy—Atmosic’s innovations enable devices to achieve perpetual battery life or operate without batteries entirely. This groundbreaking approach supports a variety of IoT applications, including wearables, asset trackers, beacons, and remotes. The company’s product lineup includes the ATM2, ATM3, ATM33, and ATM34 series, which are designed to reduce the reliance on batteries, thereby lowering costs associated with IoT deployment and maintenance for industrial users.

Kineta (Reverse Merger With Yumanity Therapeutics)

Series B in 2018
Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Founded in December 2014 by award-winning protein folding expert, Susan Lindquist, and renowned biotech industry leader, Tony Coles, Yumanity is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs. The initial focus of the company is neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). The company’s proprietary platforms have already identified one potential new target for treating Parkinson’s disease, and Yumanity is actively advancing its new chemical lead series for this condition, as well as identifying additional compounds for Alzheimer’s disease and ALS.

Paradromics

Seed Round in 2018
Paradromics, Inc. is a company focused on developing advanced brain-machine interfaces aimed at transmitting data between the brain and external devices. Founded in 2015 and based in Austin, Texas, Paradromics manufactures implantable systems that facilitate neural data decoding, converting intricate neural recordings into data streams suitable for various neural prostheses. The company's technology is designed to enhance data transmission rates, providing high-volume, bidirectional data streaming capabilities. This innovation aims to assist individuals with neurodegenerative diseases and other neurological conditions by compensating for the loss of biological connectivity. In addition to its core products, Paradromics also develops applications to support its technology solutions.

Envisagenics

Seed Round in 2017
Envisagenics, Inc. is a bioinformatics company founded in 2013 and headquartered in Huntington, New York. The company specializes in RNA therapeutics and aims to simplify complex biomedical data to expedite the development of innovative therapeutic solutions. Envisagenics leverages its advanced analytics platform, SpliceCore, which utilizes artificial intelligence and machine learning to analyze RNA sequencing data. This cloud-based platform enables researchers to identify splicing errors linked to various diseases, including genetic disorders and cancers, and to discover potential drug targets and biomarkers. By streamlining the drug discovery process through computational simulations, Envisagenics significantly reduces the time, cost, and risks associated with drug development, thereby facilitating partnerships with biopharmaceutical companies to advance RNA-based therapies.

Lightform

Seed Round in 2017
Lightform, Inc. is a computer vision and hardware company based in San Francisco, California, founded in 2014. The company specializes in developing technology for projected augmented reality, offering sound-reactive projectors, projector kits, and creator products that transform spaces through projection mapping. Lightform's innovative hardware tools and desktop application enable users to create animated content for various scenes, control projectors wirelessly from laptops or phones, and seamlessly integrate real objects with projected light. The company also provides 3D scanning options that allow for the scanning of complex scenes, automatically fine-tuning alignment and enhancing the projection mapping workflow with AI-generated effects and filters.

Stellar Labs

Series A in 2017
Stellar Labs, Inc., incorporated in 2014 and based in Burlingame, California, operates within the technology sector, focusing on the private aviation industry. The company has developed an advanced commercial operations system that integrates an all-digital distribution network, aiming to transform and enhance business aviation. Stellar Labs offers a suite of cloud-based applications designed to cater to a range of operational needs, from simple single-aircraft management to complex operations involving large fleets and multiple bases. This innovative approach positions Stellar Labs as a key player in revolutionizing the efficiency and effectiveness of private aviation services.

Mixed Dimensions

Seed Round in 2017
Mixed Dimensions Inc. is a software development company based in San Francisco, California, that specializes in the three-dimensional (3D) printing industry. Founded in 2009, the company offers several innovative solutions, including Makeprintable, a cloud-based service that optimizes 3D CAD files by fixing errors to ensure they are suitable for printing. It also provides 3D Collectible, which integrates a printing technology platform with existing 3D printers to produce customizable printed objects. Additionally, Mixed Dimensions has developed Gameprint, a platform designed to capture and share gameplay moments in a 3D environment. The company's focus on bridging the digital and physical worlds enhances user experiences in game development and 3D printing, allowing for the on-demand creation of unique, one-of-a-kind products.

Atomwise

Series A in 2017
Atomwise, Inc. is a biotechnology company specializing in deep learning artificial intelligence technology for small molecule drug discovery. Based in San Francisco and founded in 2012, the company has developed AtomNet, a pioneering AI platform that facilitates virtual screening of molecules by predicting the binding of small molecules to proteins through a statistical analysis of experimental affinity measurements and protein structures. Atomwise is focused on addressing over 600 unique disease targets and has established collaborations with over 250 partners, including prominent pharmaceutical and biotechnology firms. By leveraging its advanced technology, Atomwise aims to revolutionize the drug discovery process and advance a pipeline of small-molecule drug candidates into preclinical studies. The company was previously known as Chematria, Inc. and rebranded to Atomwise, Inc. in 2015.

Phase Four

Seed Round in 2017
Phase Four LLC, founded in 2015 and based in Pasadena, California, specializes in the manufacture of satellite propulsion systems, particularly for small satellites. The company is known for its innovative Radio Frequency Thruster (RFT), which distinguishes itself by omitting traditional components such as hollow cathodes and high voltage electronics. This design leads to substantial benefits, including a tenfold reduction in materials costs compared to legacy electric propulsion systems, a significant decrease in the size of power electronics, and versatility in propellant use. Phase Four's propulsion solutions are utilized in various space missions, including commercial, civil, and scientific endeavors, and are engineered to optimize performance while maintaining a competitive thrust-to-power ratio. The company also offers products like the CubeSats ambipolar thruster and the Maxwell plasma propulsion solution, contributing to the efficient maneuvering of satellites across diverse orbital trajectories.

Hyperfine

Series C in 2017
Hyperfine is a pioneering medical device company known for developing Swoop, the first FDA-cleared point-of-care MRI system. Swoop is designed to enhance patient access to rapid diagnosis and treatment, regardless of socioeconomic factors or geographic location. This innovative portable MRI system operates at a lower magnetic field strength than traditional MRI machines, allowing for high-quality imaging in a variety of clinical environments. Swoop can be easily transported to a patient's bedside, requires only a standard electrical outlet, and is controlled via an iPad, facilitating quick scans that support critical decision-making in settings such as emergency departments and intensive care units. Hyperfine generates revenue through the sale of its MRI devices as well as service sales, which include subscriptions for bundled devices, maintenance, and software.

Niantic

Series A in 2016
Niantic is a developer of augmented reality games that promote outdoor activity and social interaction. The company creates products that encourage movement and exploration, fostering face-to-face engagement among users. Niantic is best known for its popular games, including Ingress and Pokémon GO, which utilize its augmented reality platform to enhance mobile gaming experiences. This platform integrates features such as shared state, communication, security, and mapping, allowing users to interact within virtual environments that are seamlessly connected to the real world. Through its innovative approach, Niantic aims to enrich gaming by blending digital experiences with physical exploration.

Kineta (Reverse Merger With Yumanity Therapeutics)

Series A in 2016
Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Founded in December 2014 by award-winning protein folding expert, Susan Lindquist, and renowned biotech industry leader, Tony Coles, Yumanity is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs. The initial focus of the company is neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). The company’s proprietary platforms have already identified one potential new target for treating Parkinson’s disease, and Yumanity is actively advancing its new chemical lead series for this condition, as well as identifying additional compounds for Alzheimer’s disease and ALS.

Athira Pharma

Series A in 2016
Athira Pharma, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, focused on developing small molecules aimed at restoring neuronal health and halting neurodegeneration. The company's lead product candidate, ATH-1017, is a small molecule designed to penetrate the blood-brain barrier and acts as a hepatocyte growth factor/MET activator, currently undergoing various clinical trials for treating Alzheimer’s and Parkinson’s diseases. In addition to ATH-1017, Athira is developing several other candidates, including ATH-1019 for depression and ATH-1018 for peripheral neuropathy, which are in the preclinical stage. Founded in 2011 and initially known as M3 Biotechnology, Athira Pharma changed its name in April 2019 to reflect its mission of advancing innovative therapies to improve the lives of individuals affected by brain disorders.

Modsy

Series A in 2016
Modsy is a home design company that leverages advanced 3D graphics and computer vision technology to offer personalized interior design solutions. Founded in 2015 and based in San Francisco, the company enables customers, including new homeowners, remodelers, and renters, to visualize inspirational designs and decor within their own spaces before making any changes. Modsy's software allows users to see how furniture and decor will look in their homes, providing tailored room layouts and recommendations. It also features a shoppable marketplace, allowing customers to purchase items directly from their design plans, thereby simplifying the home design process and eliminating guesswork for both home renovators and interior designers.

Stellar Labs

Seed Round in 2015
Stellar Labs, Inc., incorporated in 2014 and based in Burlingame, California, operates within the technology sector, focusing on the private aviation industry. The company has developed an advanced commercial operations system that integrates an all-digital distribution network, aiming to transform and enhance business aviation. Stellar Labs offers a suite of cloud-based applications designed to cater to a range of operational needs, from simple single-aircraft management to complex operations involving large fleets and multiple bases. This innovative approach positions Stellar Labs as a key player in revolutionizing the efficiency and effectiveness of private aviation services.

SoundThinking

Venture Round in 2015
SoundThinking, formerly known as ShotSpotter, is a public safety technology company focused on enhancing community safety through innovative solutions and strategic advisory services for law enforcement and civic leadership. The company's flagship SafetySmart platform integrates several key tools, including ShotSpotter, an acoustic gunshot detection system; CrimeTracer, a comprehensive law enforcement search engine; CaseBuilder, an investigation management system; and ResourceRouter, software designed to optimize the deployment of patrol and anti-violence resources. By combining these technologies, SoundThinking aims to provide transformative solutions that improve public safety and support effective law enforcement practices.

Vium

Series A in 2015
Vium, Inc. is a biotechnology company focused on transforming preclinical research and enhancing animal welfare through the development of digital biomarkers. Fully accredited by AAALAC International, Vium has received commendation for its commitment to the principles of humane animal research. The company's platform, known as Digital Vivarium and Vium Cloud, integrates advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively capture and analyze physiological metrics and behaviors. This innovative approach provides researchers across biotechnology, pharmaceutical, and academic sectors with accurate data that facilitates better decision-making regarding which compounds to advance to clinical trials. Founded in 2013 and headquartered in San Mateo, California, Vium aims to accelerate the preclinical drug discovery and development pipeline while ensuring ethical standards in research practices.

Modsy

Seed Round in 2015
Modsy is a home design company that leverages advanced 3D graphics and computer vision technology to offer personalized interior design solutions. Founded in 2015 and based in San Francisco, the company enables customers, including new homeowners, remodelers, and renters, to visualize inspirational designs and decor within their own spaces before making any changes. Modsy's software allows users to see how furniture and decor will look in their homes, providing tailored room layouts and recommendations. It also features a shoppable marketplace, allowing customers to purchase items directly from their design plans, thereby simplifying the home design process and eliminating guesswork for both home renovators and interior designers.

Virtual Power Systems

Series A in 2015
Virtual Power Systems, Inc. (VPS) is building a software-defined infrastructure for data center power delivery, employing its patent-pending power system virtualization technology to provide a more flexible, mobile, scalable, and lower-cost data center architecture.

Akros Silicon

Venture Round in 2015
Akros Silicon Inc. is a fabless semiconductor company specializing in the development of power management integrated circuits (ICs) aimed at facilitating remote, network-based energy management. Founded in 2005 and based in San Jose, California, with an additional office in Shanghai, the company utilizes precision analog and mixed-signal CMOS technologies to create system-level solutions. Its product offerings include isolated DC-DC system-on-chip solutions, power-over-Ethernet powered device controllers, digital isolators, and intelligent energy management ICs. These solutions are designed to support a variety of applications, including Ethernet switches, routers, solar microinverters, VoIP phones, wireless LAN access points, and various industrial and medical equipment. Akros Silicon's innovative technology, such as its GreenEdge digital isolation, enhances the integration and efficiency of power systems, contributing to global green power management initiatives.

Keyssa

Series C in 2014
Keyssa is a developer and manufacturer of innovative contactless solid-state devices and connectors designed to facilitate seamless data transfer between devices. The company's flagship technology, Kiss Connectivity, enables secure and instantaneous communication using extremely high frequency (EHF) signals, eliminating the need for traditional metal connectors, cables, and wireless networks. This compact system, comparable in size to a coffee bean, leverages advancements in mechanical design, electromagnetics, materials science, and semiconductor technologies to transmit large volumes of data and video efficiently while minimizing battery consumption. Keyssa's products are applicable across various industries, including mobile phones, displays, automotive applications, robotic surgery, factory automation, and data centers, allowing designers to overcome the limitations of existing wired and wireless connection methods.

Eargo

Series A in 2014
Eargo, Inc. is a consumer-focused medical device company based in San Jose, California, specializing in the design and development of hearing aids for individuals with hearing loss. Founded in 2010, Eargo offers a range of rechargeable hearing aids that can be controlled via smartphone, along with online hearing screenings and virtual support services to eliminate the need for in-person visits. The company's innovative approach aims to address common barriers to hearing aid adoption, such as social stigma, accessibility, and cost, thereby enhancing the quality of life for its users. Eargo sells its products directly to consumers through online platforms, positioning itself as a modern alternative to traditional hearing aid solutions.

Wickr

Series B in 2014
Wickr Inc. is a San Francisco-based company that specializes in mobile communication applications, offering military-grade encryption for text, images, audio, and video messages. Founded in 2011, Wickr provides users with secure communication channels through its platforms, including Wickr Me, which caters to individuals, small teams, and large enterprises. The application is designed to facilitate private messaging without leaving a trace, ensuring that only the intended recipient can decrypt the messages. Wickr's technology, which employs standard encryption algorithms, supports ephemeral messaging and media, making it suitable for a diverse clientele that includes journalists, government officials, medical professionals, and everyday users. With hundreds of thousands of downloads across over 113 countries, Wickr emphasizes user privacy and security, enabling anonymous communication while supporting the principles of free expression.

CytoVale

Series A in 2014
CytoVale, Inc. is a medical technology company based in San Francisco, California, established in 2012. The company specializes in developing biomarkers that leverage the mechanical properties of individual cells, a field known as mechanomics. By utilizing microfluidics technology, CytoVale can efficiently route and physically probe single cells to measure multiple biomarkers simultaneously. This innovative approach aims to enhance early detection of immune-mediated diseases, particularly sepsis, thereby improving patient outcomes and reducing treatment costs. CytoVale's integration of cell mechanics with machine learning positions it at the forefront of revolutionizing diagnostic practices in healthcare.

SoundThinking

Venture Round in 2012
SoundThinking, formerly known as ShotSpotter, is a public safety technology company focused on enhancing community safety through innovative solutions and strategic advisory services for law enforcement and civic leadership. The company's flagship SafetySmart platform integrates several key tools, including ShotSpotter, an acoustic gunshot detection system; CrimeTracer, a comprehensive law enforcement search engine; CaseBuilder, an investigation management system; and ResourceRouter, software designed to optimize the deployment of patrol and anti-violence resources. By combining these technologies, SoundThinking aims to provide transformative solutions that improve public safety and support effective law enforcement practices.

Akros Silicon

Venture Round in 2012
Akros Silicon Inc. is a fabless semiconductor company specializing in the development of power management integrated circuits (ICs) aimed at facilitating remote, network-based energy management. Founded in 2005 and based in San Jose, California, with an additional office in Shanghai, the company utilizes precision analog and mixed-signal CMOS technologies to create system-level solutions. Its product offerings include isolated DC-DC system-on-chip solutions, power-over-Ethernet powered device controllers, digital isolators, and intelligent energy management ICs. These solutions are designed to support a variety of applications, including Ethernet switches, routers, solar microinverters, VoIP phones, wireless LAN access points, and various industrial and medical equipment. Akros Silicon's innovative technology, such as its GreenEdge digital isolation, enhances the integration and efficiency of power systems, contributing to global green power management initiatives.

SoundThinking

Venture Round in 2012
SoundThinking, formerly known as ShotSpotter, is a public safety technology company focused on enhancing community safety through innovative solutions and strategic advisory services for law enforcement and civic leadership. The company's flagship SafetySmart platform integrates several key tools, including ShotSpotter, an acoustic gunshot detection system; CrimeTracer, a comprehensive law enforcement search engine; CaseBuilder, an investigation management system; and ResourceRouter, software designed to optimize the deployment of patrol and anti-violence resources. By combining these technologies, SoundThinking aims to provide transformative solutions that improve public safety and support effective law enforcement practices.

DigiLens

Series A in 2012
DigiLens Inc. is a technology company based in Sunnyvale, California, specializing in holographic waveguide display solutions for extended reality (XR) applications. Founded in 1997 and formerly known as SBG Labs, DigiLens has developed a patented optical platform and photopolymer technology that enables original equipment manufacturers (OEMs) to create customizable XR devices for various sectors, including automotive, enterprise, consumer, avionics, and military. The company offers a range of products, such as the Crystal30 and Crystal50 lenses, which facilitate the design of waveguide-based displays. Additionally, DigiLens provides innovative solutions like the DigiLens AutoHUD, which enhances the field of view of traditional heads-up displays, and CrystalClear, an augmented reality heads-up display. Supporting its offerings, DigiLens also supplies light engines and hardware development kits, such as Insight30, to assist users in developing wearable devices.

Satmetrix

Venture Round in 2011
Satmetrix is the provider of cloud-based customer experience management (CEM) software for companies of all sizes. As co-developer of Net Promoter - the most widely accepted measure of customer loyalty and retention - Satmetrix has unrivaled real-world experience helping companies to successfully adopt Net Promoter programs and put the customer at the center of their business. Through its powerful, end-to-end CEM software platform, NPX, and complementary consulting services Satmetrix deliver increased customer loyalty, reduced attrition, improved word-of-mouth, and a clear competitive advantage. With experience on more than 1,000 deployments in 40 languages, Satmetrix accelerates the success of customer experience efforts using Net Promoter. Satmetrix is headquartered in Redwood City, California, with offices around the world.

SoundThinking

Venture Round in 2011
SoundThinking, formerly known as ShotSpotter, is a public safety technology company focused on enhancing community safety through innovative solutions and strategic advisory services for law enforcement and civic leadership. The company's flagship SafetySmart platform integrates several key tools, including ShotSpotter, an acoustic gunshot detection system; CrimeTracer, a comprehensive law enforcement search engine; CaseBuilder, an investigation management system; and ResourceRouter, software designed to optimize the deployment of patrol and anti-violence resources. By combining these technologies, SoundThinking aims to provide transformative solutions that improve public safety and support effective law enforcement practices.

Capella

Venture Round in 2011
Capella is the industry leader of wavelength selective switch (WSS) technology for use in reconfigurable optical add/drop multiplexers (ROADM) and optical cross connect (OXC) applications. Capella's intelligent subsystems provide the best performing wavelength management products on the market offering dynamic, remote reconfigurability with fully integrated optical channel monitoring (OCM), essential technology for next-generation ROADMs.

Ubicom

Series E in 2009
Ubicom is a privately held company based in Sunnyvale, California, specializing in the development of communications and media processor (CMP) and software platforms. The company focuses on addressing the specific needs of real-time interactive applications and multimedia content delivery within the digital home environment. Ubicom offers optimized system-level solutions tailored for original equipment manufacturers (OEMs) across a diverse range of products, including wireless routers, access points, VoIP gateways, and streaming media devices. Their innovative multithreaded processor design and real-time operating system, combined with application-level solutions, aim to deliver a high-quality user experience characterized by exceptional ease of use.

Radiance

Venture Round in 2008
Radiance, based in Sunnyvale, CA and founded in 2000, had investors such as Sutter Hill Ventures, Vanguard Ventures, Levensohn Venture Partners, ChevronTexaco Venture Equities and Net Partners, though this sale seems to be more of a fire sale. The company had raised at least $26 million and possibly more over the years. Radiance’s technology helps moves digital video files for the advertising and enterprise sectors. Its product development market has merged with the CMC’s engineering and integrated technology unit.

SoundThinking

Series D in 2008
SoundThinking, formerly known as ShotSpotter, is a public safety technology company focused on enhancing community safety through innovative solutions and strategic advisory services for law enforcement and civic leadership. The company's flagship SafetySmart platform integrates several key tools, including ShotSpotter, an acoustic gunshot detection system; CrimeTracer, a comprehensive law enforcement search engine; CaseBuilder, an investigation management system; and ResourceRouter, software designed to optimize the deployment of patrol and anti-violence resources. By combining these technologies, SoundThinking aims to provide transformative solutions that improve public safety and support effective law enforcement practices.

Capella

Venture Round in 2008
Capella is the industry leader of wavelength selective switch (WSS) technology for use in reconfigurable optical add/drop multiplexers (ROADM) and optical cross connect (OXC) applications. Capella's intelligent subsystems provide the best performing wavelength management products on the market offering dynamic, remote reconfigurability with fully integrated optical channel monitoring (OCM), essential technology for next-generation ROADMs.

Rapt

Venture Round in 2007
RAPT Therapeutics is a clinical-stage biopharmaceutical company specializing in immunology. It is dedicated to discovering, developing, and commercializing oral small-molecule therapies aimed at addressing significant unmet medical needs in oncology and inflammatory diseases. The company employs a proprietary discovery and development engine to create highly selective small molecules that modulate immune responses related to these conditions. RAPT has advanced two notable drug candidates: FLX475, which targets the inhibition of immunosuppressive regulatory T cells in tumors, and RPT193, which selectively inhibits type 2 T helper cells in inflamed tissues. Both candidates have progressed to clinical trials within a short timeframe since the company's inception. Additionally, RAPT is exploring several other targets in the discovery phase, including general control nonderepressible 2 and hematopoietic progenitor kinase 1.

Levanta

Venture Round in 2007
As of April 1, 2008, Levanta, Inc. went out of business. Levanta, Inc. offers Linux management and data virtualization solutions. The company offers Intrepid solutions for systems management; provisioning Linux OS and application stacks on hardware; managing servers, diskless blades, and virtual machines; tracking changes made in the Linux systems; and recovering broken systems. It offers its solutions to the financial services, entertainment, government, gaming, retail, and telecommunications industries. The company was founded in 1998 as Linuxcare, Inc. and changed its name to Levanta, Inc. in 2004. Levanta, Inc. is headquartered in San Mateo, California.

SoundThinking

Series C in 2007
SoundThinking, formerly known as ShotSpotter, is a public safety technology company focused on enhancing community safety through innovative solutions and strategic advisory services for law enforcement and civic leadership. The company's flagship SafetySmart platform integrates several key tools, including ShotSpotter, an acoustic gunshot detection system; CrimeTracer, a comprehensive law enforcement search engine; CaseBuilder, an investigation management system; and ResourceRouter, software designed to optimize the deployment of patrol and anti-violence resources. By combining these technologies, SoundThinking aims to provide transformative solutions that improve public safety and support effective law enforcement practices.

Capella

Debt Financing in 2007
Capella is the industry leader of wavelength selective switch (WSS) technology for use in reconfigurable optical add/drop multiplexers (ROADM) and optical cross connect (OXC) applications. Capella's intelligent subsystems provide the best performing wavelength management products on the market offering dynamic, remote reconfigurability with fully integrated optical channel monitoring (OCM), essential technology for next-generation ROADMs.

Akros Silicon

Series B in 2007
Akros Silicon Inc. is a fabless semiconductor company specializing in the development of power management integrated circuits (ICs) aimed at facilitating remote, network-based energy management. Founded in 2005 and based in San Jose, California, with an additional office in Shanghai, the company utilizes precision analog and mixed-signal CMOS technologies to create system-level solutions. Its product offerings include isolated DC-DC system-on-chip solutions, power-over-Ethernet powered device controllers, digital isolators, and intelligent energy management ICs. These solutions are designed to support a variety of applications, including Ethernet switches, routers, solar microinverters, VoIP phones, wireless LAN access points, and various industrial and medical equipment. Akros Silicon's innovative technology, such as its GreenEdge digital isolation, enhances the integration and efficiency of power systems, contributing to global green power management initiatives.

Veraz Networks

Venture Round in 2007
Veraz Networks, Inc. specializes in voice infrastructure solutions for wireline and wireless service providers. Founded in 2001 and headquartered in San Jose, California, the company offers a range of products that include bandwidth optimization tools, such as the I-Gate 4000 family of media gateways and session bandwidth optimizers, as well as digital circuit multiplication equipment. Its switching products feature the ControlSwitch product family, network-adaptive border controllers, and session border controllers, all designed to facilitate the transport, conversion, and management of voice and data traffic over both time-division multiplexing and IP networks. In addition to its core products, Veraz Networks provides hardware and software maintenance, support, installation, training, and other professional services. The company markets its offerings through a direct sales force and various indirect sales channels, enabling the delivery of converged voice-data services across packet-based networks.

KnowNow

Venture Round in 2006
KnowNow delivers RSS services to large companies. KnowNow's live information management solutions are designed to increase productivity, efficiency, and profitability for companies around the world.

Reconnex

Series C in 2006
Reconnex provides organizations with complete visibility into and protection over critical content—on all ports and for all types of connections—through its purpose-built appliance solutions. Reconnex protects all information assets, regardless of how the information is stored, secured, or communicated, and without requiring upfront knowledge of what needs to be protected. It provides a comprehensive data loss solution that goes beyond the obvious to protect unknown data you can't even fathom today, or simply don't know about. Today, Reconnex protects the information assets for over one million users with key customers including WebEx Communications, The George Washington University, SIRVA and Maimonides Medical Center.

Ubicom

Series C in 2006
Ubicom is a privately held company based in Sunnyvale, California, specializing in the development of communications and media processor (CMP) and software platforms. The company focuses on addressing the specific needs of real-time interactive applications and multimedia content delivery within the digital home environment. Ubicom offers optimized system-level solutions tailored for original equipment manufacturers (OEMs) across a diverse range of products, including wireless routers, access points, VoIP gateways, and streaming media devices. Their innovative multithreaded processor design and real-time operating system, combined with application-level solutions, aim to deliver a high-quality user experience characterized by exceptional ease of use.

Rapt

Series D in 2006
RAPT Therapeutics is a clinical-stage biopharmaceutical company specializing in immunology. It is dedicated to discovering, developing, and commercializing oral small-molecule therapies aimed at addressing significant unmet medical needs in oncology and inflammatory diseases. The company employs a proprietary discovery and development engine to create highly selective small molecules that modulate immune responses related to these conditions. RAPT has advanced two notable drug candidates: FLX475, which targets the inhibition of immunosuppressive regulatory T cells in tumors, and RPT193, which selectively inhibits type 2 T helper cells in inflamed tissues. Both candidates have progressed to clinical trials within a short timeframe since the company's inception. Additionally, RAPT is exploring several other targets in the discovery phase, including general control nonderepressible 2 and hematopoietic progenitor kinase 1.

BigFix

Series E in 2005
BigFix, Inc. provides an IT security and operations platform that enables real-time visibility and control of globally distributed desktop, mobile, and server computers. The company offers BigFix Platform that instruments a messaging and management nervous system, as well as distributes the work of managing IT infrastructures to managed devices; BigFix AntiThreat for endpoint security; BigFix IT Policy Enforcement to set and enforce security policies and processes; and BigFix Systems Management that focuses on automating IT operations tasks. It also provides BigFix Policy Content Modules to develop custom management content. In addition, the company offers products support, consumer edition support, and professional services. It serves companies, government agencies, and public sector institutions. The company was founded in 1997 and is based in Emeryville, California.

Caymas Systems

Series C in 2005
As of June 11, 2007, Caymas Systems, Inc. was acquired by Citrix Systems, Inc. Caymas Systems, Inc. offers identity-driven access gateways for international enterprise networks. The company's identity-driven access gateways deliver universal access, identity-based access control, integrated application security, federated policy enforcement, and radical price/performance solutions. Its appliances provides a single platform for SSL VPN remote access and internal access control, endpoint security, and behavioral and data monitoring with centralized policy management. The company was founded in 2002 and is headquartered in Petaluma, California.

BroadLogic Network Technologies

Series C in 2004
BroadLogic Network Technologies, Inc. specializes in designing and supplying video-processing mixed signal semiconductors for broadband network operators. Founded in 1998 and headquartered in San Jose, California, the company provides essential technologies that enable services such as video-on-demand, digital video, voice, and high-speed data for consumers. Its flagship product, TeraPIX, is a multi-channel video processor that decodes digital video streams, facilitating both analog and digital service tiers. This technology allows cable-ready devices, including televisions and DVRs, to access a variety of programs. Additionally, BroadLogic develops Wideband Receivers for new subscriber devices and collaborates with key industry partners, enhancing its offerings for system operators and manufacturers. The company also maintains a development center in Beijing, China.

Radiance Technologies

Series C in 2004
Radiance Technologies specializes in the managed delivery of digital packages, focusing on the distribution and management of large digital video files. The company's flagship product, the TrueDelivery System, utilizes patent-pending digital logistics technology to enhance digital delivery over IP networks. This innovative approach allows for efficient handling of digital assets, making it easier for clients to manage and distribute their digital content effectively.

Ubicom

Series B in 2004
Ubicom is a privately held company based in Sunnyvale, California, specializing in the development of communications and media processor (CMP) and software platforms. The company focuses on addressing the specific needs of real-time interactive applications and multimedia content delivery within the digital home environment. Ubicom offers optimized system-level solutions tailored for original equipment manufacturers (OEMs) across a diverse range of products, including wireless routers, access points, VoIP gateways, and streaming media devices. Their innovative multithreaded processor design and real-time operating system, combined with application-level solutions, aim to deliver a high-quality user experience characterized by exceptional ease of use.

Informative

Venture Round in 2004
Informative is a marketing company based in South San Francisco, California, specializing in online tools designed to identify customer priorities and foster brand communities. Founded in 1999, initially as Getwebby.com, the company underwent several name changes, becoming Informative, Inc. in 2002. Informative offers a range of services including surveys, community forums, blogging, and profiling, catering to diverse sectors such as advertising, media, consumer products, financial services, pharmaceuticals, software, and consumer electronics. The company's marketing analytics services further support advertising agencies and marketing firms in understanding consumer behavior and enhancing engagement.

Veraz Networks

Series A in 2003
Veraz Networks, Inc. specializes in voice infrastructure solutions for wireline and wireless service providers. Founded in 2001 and headquartered in San Jose, California, the company offers a range of products that include bandwidth optimization tools, such as the I-Gate 4000 family of media gateways and session bandwidth optimizers, as well as digital circuit multiplication equipment. Its switching products feature the ControlSwitch product family, network-adaptive border controllers, and session border controllers, all designed to facilitate the transport, conversion, and management of voice and data traffic over both time-division multiplexing and IP networks. In addition to its core products, Veraz Networks provides hardware and software maintenance, support, installation, training, and other professional services. The company markets its offerings through a direct sales force and various indirect sales channels, enabling the delivery of converged voice-data services across packet-based networks.

BigFix

Series B in 2002
BigFix, Inc. provides an IT security and operations platform that enables real-time visibility and control of globally distributed desktop, mobile, and server computers. The company offers BigFix Platform that instruments a messaging and management nervous system, as well as distributes the work of managing IT infrastructures to managed devices; BigFix AntiThreat for endpoint security; BigFix IT Policy Enforcement to set and enforce security policies and processes; and BigFix Systems Management that focuses on automating IT operations tasks. It also provides BigFix Policy Content Modules to develop custom management content. In addition, the company offers products support, consumer edition support, and professional services. It serves companies, government agencies, and public sector institutions. The company was founded in 1997 and is based in Emeryville, California.

Rapt

Series C in 2002
RAPT Therapeutics is a clinical-stage biopharmaceutical company specializing in immunology. It is dedicated to discovering, developing, and commercializing oral small-molecule therapies aimed at addressing significant unmet medical needs in oncology and inflammatory diseases. The company employs a proprietary discovery and development engine to create highly selective small molecules that modulate immune responses related to these conditions. RAPT has advanced two notable drug candidates: FLX475, which targets the inhibition of immunosuppressive regulatory T cells in tumors, and RPT193, which selectively inhibits type 2 T helper cells in inflamed tissues. Both candidates have progressed to clinical trials within a short timeframe since the company's inception. Additionally, RAPT is exploring several other targets in the discovery phase, including general control nonderepressible 2 and hematopoietic progenitor kinase 1.

Covigo

Venture Round in 2002
Covigo is a software company that specializes in developing multi-channel application platforms designed to facilitate the rapid and cost-effective deployment of mobile, web, and portal applications. Their products focus on enhancing operational efficiency and improving user experience for both enterprises and operators. The Covigo Mobility Suite for Enterprises allows organizations to create offline and online applications for various devices, enabling users to work without constant network connectivity while providing timely alerts based on business events. For telecommunications operators, the Covigo Mobility Suite optimizes service rollout, significantly reducing time and costs, and supports the integration of third-party applications. Additionally, Covigo's Portal Enhancement Suite enables companies to build and deploy personalized portal applications quickly, offering a comprehensive view of business processes to employees, customers, and partners. With a focus on usability and adaptability, Covigo's solutions address the evolving needs of businesses in a dynamic digital landscape.

NexVerse Networks

Venture Round in 2001
NexVerse Networks supplies generation softswitch solutions based on the ipVerse ControlSwitch platform. The company was founded in October 2001 and is based in San Jose, California.

Velosel

Series B in 2001
Velosel Corporation specializes in collaborative product information management software designed for retailers and consumer goods manufacturers. Its flagship product, Velosel5, enables effective internal product information management and synchronization with trading partners across the enterprise value chain. The company also offers implementation, support, and training services to ensure optimal use of its software. Founded in 1999 and headquartered in Santa Clara, California, with an additional office in Princeton, New Jersey, Velosel aims to enhance the connection between suppliers and buyers, streamlining electronic sales channels, including corporate e-procurement systems and e-marketplaces, while facilitating catalog and order management.

Vertical Networks

Series F in 2001
Vertical Networks is a distributor of IP-PBX software and communications solutions for branch offices and stores, delivers customizable solutions to several industries, including financial services, healthcare, publishing, and retail.

Vertical Networks

Venture Round in 2000
Vertical Networks is a distributor of IP-PBX software and communications solutions for branch offices and stores, delivers customizable solutions to several industries, including financial services, healthcare, publishing, and retail.

SingleSourceIT

Series A in 2000
SingleSourceIT provides internet-based IT supply chain services.

Atheros Communications

Venture Round in 2000
Atheros Communications is a semiconductors company specializing in radio frequency, mixed signal, and digital semiconductor design services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.